LMR Partners’s Mineralys Therapeutics MLYS Stock Holding History
Bought
Maintained
Sold
Other funds holding MLYS
LMR Partners's MLYS Position: Q3 2026 in Review
LMR Partners opened a new position in Mineralys Therapeutics (MLYS) in Q3 2026: 20,000 shares worth $503K. The stake represents ﹤0.01% of the portfolio and ranks #1214 among its holdings.
219 funds tracked by Wall St. Rank hold MLYS as of Q3 2026.
- LMR Partners held 20,000 shares of Mineralys Therapeutics worth $503K as of Q3 2026.
- Mineralys Therapeutics was a new LMR Partners position in Q3 2026.
- Mineralys Therapeutics made up ﹤0.01% of LMR Partners's portfolio in Q3 2026, its #1214 holding.
- 219 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q3 2026.
Based on LMR Partners's 13F filing for Q3 2026, filed 16 Nov 2026.